Study directory

Mental health studies with practical context.

Compare studies and check their requirements with the research team.

Back to overview

10612studies shown

Showing 7,429-7,440 of 10,612

Drug study icon

CompletedNCT00592930

Olanzapine in the Treatment of Eating disorders

This summary needs review. Please check the official study record and contact the research team for details.

In United States

Eating disordersDrugFrom 12 Years to 23 Years

Countries: United States
Sponsor: Northwell Health
Condition: Eating disorders

Drug study icon

CompletedNCT00320489

Olanzapine Pamoate Depot Versus Oral Olanzapine on Treatment Outcomes in Outpatients With Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

In United States

SchizophreniaDrugFrom 18 Years to 65 Years

Countries: United States, France, Canada, ...
Sponsor: Eli Lilly and Company
Condition: Schizophrenia

Drug study icon

CompletedNCT00113594

Olanzapine Treated Adolescents With Schizophrenia or Bipolarity type I

This summary needs review. Please check the official study record and contact the research team for details.

In United States

Bipolarity, SchizophreniaDrugFrom 13 Years to 17 Years

Countries: United States, Russia
Sponsor: Eli Lilly and Company
Condition: Bipolarity, Schizophrenia

Drug study icon

CompletedNCT00034580

Olanzapine Versus Active Comparator in the Treatment of Bipolarity type I

This summary needs review. Please check the official study record and contact the research team for details.

In United States

BipolarityDrugFrom 18 Years to 70 Years

Countries: United States
Sponsor: Eli Lilly and Company
Condition: Bipolarity

Drug study icon

CompletedNCT01170117

Olanzapine Versus Placebo for Outpatients With Eating disorders

This summary needs review. Please check the official study record and contact the research team for details.

In United States

Eating disordersDrugFrom 18 Years to 75 Years

Countries: United States, Canada
Sponsor: New York State Psychiatric Institute
Condition: Eating disorders

Drug study icon

CompletedNCT00050206

Olanzapine Versus Placebo in the Treatment of Mania in Adolescents With Bipolarity type I

This summary needs review. Please check the official study record and contact the research team for details.

In United States

BipolarityDrugFrom 13 Years to 17 Years

Countries: United States
Sponsor: Eli Lilly and Company
Condition: Bipolarity

Drug study icon

CompletedNCT00094549

Olanzapine vs. Comparator and Placebo in the Treatment of people with Bipolarity type I

This summary needs review. Please check the official study record and contact the research team for details.

In United States

BipolarityDrugFrom 18 Years to 65 Years

Countries: United States, Lithuania, Romania, ...
Sponsor: Eli Lilly and Company
Condition: Bipolarity

Drug study icon

CompletedNCT00485771

Olanzapine/Fluoxetine Combination Versus Comparator in the Treatment of Bipolar I Depression

This summary needs review. Please check the official study record and contact the research team for details.

In United States

Bipolarity, DepressionDrugFrom 18 Years to 60 Years

Countries: United States
Sponsor: Eli Lilly and Company
Condition: Bipolarity, Depression

Behavioral study icon

CompletedNCT07153029

Older Adults, Methadone, and Cognitive Function

This summary needs review. Please check the official study record and contact the research team for details.

In United States

AddictionBehavioralOver 55 Years

Countries: United States
Sponsor: University of Maryland, Baltimore
Condition: Addiction

Behavioral study icon

CompletedNCT05577377

OM and Trauma Study

This summary needs review. Please check the official study record and contact the research team for details.

In United States

PTSDBehavioralOver 18 Years

Countries: United States
Sponsor: Institute of OM Foundation
Condition: PTSD

Other study type icon

CompletedNCT00586222

Omega 3 Fatty Acid study

This summary needs review. Please check the official study record and contact the research team for details.

In United States

BipolarityOtherFrom 12 Years to 18 Years

Countries: United States
Sponsor: Mayo Clinic
Condition: Bipolarity

Behavioral study icon

CompletedNCT01507753

Omega-3 and Therapy Study for Childhood Bipolarity- Not Otherwise Specified

This summary needs review. Please check the official study record and contact the research team for details.

In United States

BipolarityBehavioralFrom 7 Years to 14 Years

Countries: United States
Sponsor: L. Eugene Arnold
Condition: Bipolarity

Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.